Level IV tumor thrombus in non-metastatic renal cell cancer? No, thanks. Level II is better. Lessons learned from a case report

由 Galosi, Andrea Benedetto, Papaveri, Alessio, Castellani, Daniele, Agostini, Edoardo, Burattini, Luciano, Dell’Atti, Lucio
發表在 Urol Case Rep (2021)

Pathogenic and Diagnostic Potential of BLCA-1 and BLCA-4 Nuclear Proteins in Urothelial Cell Carcinoma of Human Bladder

由 Santoni, Matteo, Catanzariti, Francesco, Minardi, Daniele, Burattini, Luciano, Nabissi, Massimo, Muzzonigro, Giovanni, Cascinu, Stefano, Santoni, Giorgio
出版 2012

Progress of Molecular Targeted Therapies for Advanced Renal Cell Carcinoma

由 Conti, Alessandro, Santoni, Matteo, Amantini, Consuelo, Burattini, Luciano, Berardi, Rossana, Santoni, Giorgio, Cascinu, Stefano, Muzzonigro, Giovanni
出版 2013

Protracted low doses of temozolomide for the treatment of patients with recurrent glioblastoma: A phase II study

由 SANTONI, MATTEO, PACCAPELO, ALESSANDRO, BURATTINI, LUCIANO, BIANCONI, MARISTELLA, CARDINALI, MASSIMO, FABBIETTI, LETIZIA, TRIGNANI, ROBERTO, RYCHLICKI, FRANCO, CASCINU, STEFANO
出版 2012

Seminoma Retroperitoneal Relapse 23 Years After Surgery

由 Crocetti, Sonia, Tassone, Laura, Torniai, Mariangela, Pierantoni, Chiara, Burattini, Luciano, Mandolesi, Alessandra, Di Benedetto, Maika, Mantello, Giovanna, Scarpelli, Marina, Berardi, Rossana
發表在 Oncol Ther (2021)

Computational analysis of the mutations in BAP1, PBRM1 and SETD2 genes reveals the impaired molecular processes in renal cell carcinoma

由 Piva, Francesco, Giulietti, Matteo, Occhipinti, Giulia, Santoni, Matteo, Massari, Francesco, Sotte, Valeria, Iacovelli, Roberto, Burattini, Luciano, Santini, Daniele, Montironi, Rodolfo, Cascinu, Stefano, Principato, Giovanni
發表在 Oncotarget (2015)

Efficacy and safety of second-line fotemustine in elderly patients with recurrent glioblastoma

由 Santoni, Matteo, Scoccianti, Silvia, Lolli, Ivan, Fabrini, Maria Grazia, Silvano, Giovanni, Detti, Beatrice, Perrone, Franco, Savio, Giuseppina, Iacovelli, Roberto, Burattini, Luciano, Berardi, Rossana, Cascinu, Stefano
出版 2013

[(11)C]-Methionine Positron Emission Tomography in the Postoperative Imaging and Followup of Patients with Primary and Recurrent Gliomas

由 Santoni, Matteo, Nanni, Cristina, Bittoni, Alessandro, Polonara, Gabriele, Paccapelo, Alessandro, Trignani, Roberto, De Lisa, Mariagrazia, Rychlicki, Franco, Burattini, Luciano, Berardi, Rossana, Fanti, Stefano, Cascinu, Stefano
出版 2014

Angiogenesis genotyping in the selection of first-line treatment with either sunitinib or pazopanib for advanced renal cell carcinoma

由 Bianconi, Maristella, Faloppi, Luca, Loretelli, Cristian, Zizzi, Antonio, Giampieri, Riccardo, Bittoni, Alessandro, Andrikou, Kalliopi, Prete, Michela Del, Burattini, Luciano, Montironi, Rodolfo, Scartozzi, Mario, Cascinu, Stefano
發表在 Oncotarget (2016)

Role of STAT3 pathway in genitourinary tumors

由 Santoni, Matteo, Conti, Alessandro, Piva, Francesco, Massari, Francesco, Ciccarese, Chiara, Burattini, Luciano, Cheng, Liang, Lopez-Beltran, Antonio, Scarpelli, Marina, Santini, Daniele, Tortora, Giampaolo, Cascinu, Stefano, Montironi, Rodolfo
發表在 Future Sci OA (2015)

Risk of recurrence and conditional survival in complete responders treated with TKIs plus or less locoregional therapies for metastatic renal cell carcinoma

由 Santini, Daniele, Santoni, Matteo, Conti, Alessandro, Procopio, Giuseppe, Verzoni, Elena, Galli, Luca, di Lorenzo, Giuseppe, De Giorgi, Ugo, De Lisi, Delia, Nicodemo, Maurizio, Maruzzo, Marco, Massari, Francesco, Buti, Sebastiano, Altobelli, Emanuela, Biasco, Elisa, Ricotta, Riccardo, Porta, Camillo, Vincenzi, Bruno, Papalia, Rocco, Marchetti, Paolo, Burattini, Luciano, Berardi, Rossana, Muto, Giovanni, Montironi, Rodolfo, Cascinu, Stefano, Tonini, Giuseppe
發表在 Oncotarget (2016)